Solésence, Inc. reported a total revenue of $62.1 million for the fiscal year ending December 31, 2025, marking a 18.5% increase from $52.3 million in 2024. The company's product revenue, which constitutes the majority of its income, rose to $61.8 million, up from $51.9 million the previous year. Despite this growth, Solésence experienced a decline in net income, which fell to $1.8 million from $4.2 million in 2024. The decrease in profitability was attributed to increased costs of revenue, which rose to $46.0 million from $36.2 million, driven by higher material and labor costs associated with the increased sales volume.
The company underwent significant strategic changes during the fiscal year, including a rebranding from Nanophase Technologies Corporation to Solésence, Inc. on March 7, 2025. This rebranding reflects a renewed focus on skin health innovation across beauty, health, and wellness categories. Solésence has also expanded its consumer products line, which now accounts for 88% of total revenue, up from 85% in the previous year. The company has developed over 950 stock-keeping units (SKUs) of fully formulated cosmetic products, primarily in the prestige beauty segment, and has received multiple industry awards for its innovative formulations.
Operationally, Solésence reported a total employee count of 115 full-time staff as of December 31, 2025, with an additional 90 to 225 temporary employees based on demand. The company has also seen a significant increase in customer engagement, with its three largest customers accounting for 55% of total revenue in 2025, compared to 45% in 2024. The company’s manufacturing capabilities have been consolidated into two facilities in the Chicago area, which are compliant with current Good Manufacturing Practice (cGMP) standards enforced by the FDA.
Looking ahead, Solésence anticipates continued growth in its consumer products segment, driven by increasing demand for its proprietary technologies and formulations. The company plans to focus on expanding its market presence both domestically and internationally, particularly in the prestige beauty sector. However, management has acknowledged potential challenges, including supply chain pressures and the need to maintain competitive pricing amidst rising costs. The company remains committed to leveraging its technological advantages to enhance product performance and meet evolving consumer demands.
About SOLESENCE, INC.
Solesence, Inc. (formerly Nanophase Technologies) specializes in scientifically-driven skin health and beauty solutions, including proprietary active pharmaceutical ingredients (APIs) and fully formulated consumer products. The company develops mineral-based UV protection, environmental defense, and aesthetic skincare products for prestige and mass markets. Its core value lies in innovative nanotechnology, formulation expertise, and a vertically integrated business model serving global brand partners.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.